Bio-engineer Tim Van Hauwermeiren co-founded biotech company Argen-X in 2008, together with Hans de Haard and Torsten Dreier.
Industriepark Zwijnaarde 7
Until that time, he was senior business development executive at Ablynx. Prior to joining Ablynx, Van Hauwermeiren held various management positions with the Procter & Gamble Company in R&D and corporate new business development, where he conceived and developed several new products.
He was awarded the 2000 F&HC New Business Development Award for Outstanding Courage and Commitment and was nominated for the John Smale Innovation Award in 2001. As a chairman, Van Hauwermeiren holds positions in Aelin Therapeutics and iTeos Pharmaceuticals.